A comprehensive view of MSD Research Laboratories. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca and MSD's Lynparza abiraterone and prednisone or prednisolone combination approved by FDA to treat BRCA-mutated metastatic castration-resistant prostate cancer; drug reduced disease progression or death by 76% compared to abiraterone alone
Published: June 01, 2023 by AstraZeneca AB

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count